{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:41:32Z","timestamp":1771670492122,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H06251"],"award-info":[{"award-number":["JP16H06251"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H00462"],"award-info":[{"award-number":["JP20H00462"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21tm0424220"],"award-info":[{"award-number":["JP21tm0424220"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Relapsing polychondritis (RP) is a rare inflammatory disease characterized by recurrent inflammation and destruction of cartilaginous tissues. RP has characteristics of autoimmune disease and some reports have noted co-occurrence with autoimmune thyroid disease (AITD), consisting of Graves\u2019 disease (GD) and Hashimoto thyroiditis (HT). However, there have been no detailed studies on the co-occurrence of RP and AITD. In this study, we aimed to determine whether patients with RP tend to be complicated with AITD. We also analyzed the clinical and genetic profiles of patients in whom these diseases co-occur.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We recruited 117 patients with RP and reviewed their medical records. Furthermore, we genotyped Human Leucocyte Antigen (HLA)-A, B Cw, DRB1, DQB1, and DPB1 alleles for 93 of the 117 patients. The prevalence of AITD among the patients with RP was compared with that among the general Japanese population. We also analyzed the clinical and genetic features of the patients with both RP and AITD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of GD among the patients with RP was 4.3% (5 among 117 patients), significantly higher than that among Japanese (0.11%) (p\u2009=\u20092.44\u2009\u00d7\u200910<jats:sup>\u20137<\/jats:sup>, binomial test). RP patients with GD tended to have nasal involvement (p\u2009=\u20090.023) (odds ratio (OR) 2.58) and HLA-DPB1*02:02 (p\u2009=\u20090.035, OR 10.41). We did not find significant enrichment of HT in patients with RP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with RP appear to be at elevated risk of GD. Nasal involvement and HLA-DPB1*02:02 characterize the subset of RP patients with GD, which may guide attempts to characterize a distinct subtype of RP for precision medicine.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02261-5","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:03:00Z","timestamp":1652140980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases"],"prefix":"10.1186","volume":"17","author":[{"given":"Toshiki","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Yurugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taira","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneyasu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Ohmura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneyo","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6452-4095","authenticated-orcid":false,"given":"Chikashi","family":"Terao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"2261_CR1","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1056\/NEJM197811302992202","volume":"299","author":"JM Foidart","year":"1978","unstructured":"Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med. 1978;299:1203\u20137.","journal-title":"N Engl J Med"},{"key":"2261_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/art.1780360513","volume":"36","author":"B Lang","year":"1993","unstructured":"Lang B, Rothenfusser A, Lanchbury JS, Rauh G, Breedveld FC, Urlacher A, et al. Susceptibility to relapsing polychondritis is associated with HLA-DR4. Arthritis Rheum. 1993;36:660\u20134.","journal-title":"Arthritis Rheum"},{"key":"2261_CR3","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/rheumatology\/kew233","volume":"55","author":"C Terao","year":"2016","unstructured":"Terao C, Yoshifuji H, Yamano Y, Kojima H, Yurugi K, Miura Y, et al. Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases. Rheumatology. 2016;55:1686\u201392.","journal-title":"Rheumatology"},{"key":"2261_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0002-9343(85)90547-9","volume":"79","author":"GS Firestein","year":"1985","unstructured":"Firestein GS, Gruber HE, Weisman MH, Zvaifler NJ, Barber J, O\u2019Duffy JD. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Beh\u00e7et\u2019s disease. Am J Med. 1985;79:65\u201372.","journal-title":"Am J Med"},{"key":"2261_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OARRR.S142892","volume":"10","author":"FK Lekpa","year":"2018","unstructured":"Lekpa FK, Chevalier X. Refractory relapsing polychondritis: challenges and solutions. Open Access Rheumatol. 2018;10:1\u201311.","journal-title":"Open Access Rheumatol"},{"key":"2261_CR6","doi-asserted-by":"publisher","first-page":"E379","DOI":"10.1210\/jc.2013-2841","volume":"99","author":"S Ueda","year":"2014","unstructured":"Ueda S, Oryoji D, Yamamoto K, Noh JY, Okamura K, Noda M, et al. Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J Clin Endocrinol Metab. 2014;99:E379\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"2261_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1507\/endocrj.50.429","volume":"50","author":"T Akamizu","year":"2003","unstructured":"Akamizu T, Nakamura Y, Tamaoki A, Inaba Y, Amino N, Seino Y. Prevalence and clinico-epidemiology of familial Graves\u2019 disease in Japan based on nationwide epidemiologic survey in 2001. Endocr J. 2003;50:429\u201336.","journal-title":"Endocr J"},{"key":"2261_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/ije\/16.4.545","volume":"16","author":"K Okamura","year":"1987","unstructured":"Okamura K, Nakashima T, Ueda K, Inoue K, Omae T, Fijishima M. Thyroid disorders in the general population of Hisayama Japan, with special reference to prevalence and sex differences. Int J Epidemiol. 1987;16:545\u20139.","journal-title":"Int J Epidemiol"},{"key":"2261_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2188\/jea.JE20180150","volume":"28","author":"T Ninomiya","year":"2018","unstructured":"Ninomiya T. Japanese legacy cohort studies: the Hisayama study. J Epidemiol. 2018;28:444\u201351.","journal-title":"J Epidemiol"},{"key":"2261_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.humimm.2006.02.023","volume":"67","author":"M Takahashi","year":"2006","unstructured":"Takahashi M, Yasunami M, Kubota S, Tamai H, Kimura A. HLA-DPB1*0202 is associated with a predictor of good prognosis of Graves\u2019 disease in the Japanese. Hum Immunol. 2006;67:47\u201352.","journal-title":"Hum Immunol"},{"key":"2261_CR11","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/art.39157","volume":"67","author":"C Terao","year":"2015","unstructured":"Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y, et al. Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis Rheumatol. 2015;67:2226\u201332.","journal-title":"Arthritis Rheumatol"},{"key":"2261_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/03009742.2015.1060521","volume":"45","author":"C Terao","year":"2016","unstructured":"Terao C, Yoshifuji H, Nakajima T, Yukawa N, Matsuda F, Mimori T. Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application. Scand J Rheumatol. 2016;45:80\u20132.","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"2261_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.autrev.2016.02.013","volume":"15","author":"L Longo","year":"2016","unstructured":"Longo L, Greco A, Rea A, Lo Vasco VR, De Virgilio A, De Vincentiis M. Relapsing polychondritis: a clinical update. Autoimmun Rev. 2016;15(6):539\u201343.","journal-title":"Autoimmun Rev"},{"key":"2261_CR14","first-page":"7184163","volume":"2018","author":"N Xu","year":"2018","unstructured":"Xu N, Cui Y, Xie T, Zheng M. Comparative efficacy of medical treatments for thyroid eye disease: a network meta-analysis. J Ophthalmol. 2018;2018:7184163.","journal-title":"J Ophthalmol"},{"key":"2261_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","volume":"55","author":"LP McAdam","year":"1976","unstructured":"McAdam LP, O\u2019Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976;55:193\u2013215.","journal-title":"Medicine (Baltimore)"},{"key":"2261_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1288\/00005537-197906000-00009","volume":"89","author":"JM Damiani","year":"1979","unstructured":"Damiani JM, Levine HL. Relapsing polychondritis\u2014report of ten cases. Laryngoscope. 1979;89:929\u201346.","journal-title":"Laryngoscope"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02261-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02261-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02261-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:03:05Z","timestamp":1652140985000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02261-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2261"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02261-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"4 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Kyoto University Graduate School and Faculty of Medicine, Ethics Committee, and the ethics committee of St Marianna University School of Medicine. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from all the participants in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}